三湘印象(000863.SZ):擬籌劃控制權變更事項 11月13日起停牌
格隆匯11月12日丨三湘印象(000863.SZ)公佈,公司於2023年11月10日收到控股股東上海三湘投資控股有限公司(以下簡稱“三湘控股”)及實際控制人黃輝先生通知,其正在籌劃公司控制權變更相關事宜,具體方案涉及股份轉讓及向特定對象發行股份。前述交易事項如順利進行,預計股份轉讓比例約佔公司總股本的24%-26%,同時公司擬籌劃向特定對象發行不超過發行前公司總股本30%的股份,具體方案以各方簽署的相關協議為準。本次交易對手方為國有控股公司,主要從事地產開發相關業務。本次交易事項需有關部門進行事前審批。公司股票於2023年11月13日開市起停牌,預計停牌時間不超過2個交易日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.